{"filings":[{"id":1111438,"accession_number":"0001206774-26-000333","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2026-06-17T20:15:35+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Clorox appoints Chris Hyder as COO, Nina Barton as Chief Growth & Strategy Officer; simplifies operating structure","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Chris Hyder named EVP & COO effective June 17; base salary $800k, STI target 100%, $4M RSU grant (3-yr vest).","Nina Barton becomes EVP & Chief Growth & Strategy Officer, leading innovation, value superiority, and strategy.","Streamlined structure: all business units now under COO; commercial functions report to Barton for faster execution.","Board continues CEO search with leading firm (announced May 28); comprehensive search underway for next CEO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":721802,"accession_number":"0001206774-26-000296","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2026-05-28T20:05:35+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Clorox CEO Linda Rendle steps down for health reasons; board initiates search","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Rendle will remain Chair and CEO during the search and until the new CEO is appointed.","She will serve in an advisory role after the new CEO is named to ensure a smooth transition.","Search led by an independent CEO search committee with support of a leading executive search firm.","Rendle has been CEO for six years and with Clorox for over two decades; CFO Luc Bellet to attend conference June 3."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":13287,"accession_number":"0001193125-26-216807","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2026-05-11T20:15:18+00:00","items":["8.01","9.01"],"status":"ready","headline":"Clorox issues $1.5B of senior notes in three tranches maturing 2031-2036","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$550M of 4.700% Senior Notes due 2031 issued.","$400M of 4.950% Senior Notes due 2033 issued.","$550M of 5.250% Senior Notes due 2036 issued.","Offering closed on May 11, 2026; underwriting agreement signed May 6, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97731,"accession_number":"0000021076-26-000016","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q3 net sales flat at $1.67B; adj. EPS +13% to $1.64; gross margin down 140bps","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Diluted EPS $1.54 (+3% YoY); adjusted EPS $1.64 (+13% YoY) on cost savings and lower ad spend.","Organic sales decreased 1%; Household +3%, Lifestyle -9%, International +8%.","Gross margin 43.2%, down 140bps on higher manufacturing/logistics costs and unfavorable mix.","Net cash from operations YTD $282M, down 59% due to Glad JV termination payment; adjusted free cash flow $637M.","Company reaffirms focus on execution amid challenging consumer and cost environment."],"consensus_eps_estimate":null,"consensus_eps_actual":3.47,"consensus_revenue_estimate":null,"consensus_revenue_actual":4772000000.0,"consensus_period":"2026-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97730,"accession_number":"0001206774-26-000173","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2026-04-01T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Clorox completes acquisition of GOJO Industries (Purell) – expands health & hygiene portfolio","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Clorox closed purchase of all membership interests of GOJO Industries, maker of Purell.","GOJO business renamed Clorox Purell, led by President Carey Jaros.","Clorox Purell will be based in Akron, Ohio; facilities in Ashland, Cuyahoga Falls, Wooster.","Combination aims to leverage complementary consumer and B2B capabilities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":112869,"accession_number":"0001206774-26-000133","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2026-03-10T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Clorox enters $2.25B credit facilities to fund GOJO (PURELL) acquisition","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Entered $1B 364-day revolver and $1.25B delayed draw term loan on March 6, 2026, both unsecured and unguaranteed.","Proceeds to finance part of the GOJO acquisition consideration, pay fees, and repay GOJO indebtedness.","Revolver matures March 5, 2027 (convertible to term loan to March 5, 2028); term loan matures March 5, 2027.","Interest based on Base Rate or Term SOFR plus margin tied to Clorox's credit rating; single financial covenant for consolidated interest coverage ratio.","JPMorgan Chase, Citibank, and Wells Fargo act as joint lead arrangers, bookrunners, and administrative agents."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":112868,"accession_number":"0000021076-26-000008","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2026-02-03T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q2 FY2026 sales down 1% to $1.67B, EPS $1.29, reaffirms outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.67B (-1% YoY); organic sales -1%; gross margin 43.2% (-60 bps).","Diluted EPS $1.29 (-16% YoY); adjusted EPS $1.39 (-10% YoY).","YTD operating cash flow $404M (+1%); free cash flow $326M (10.5% of sales).","Segment: Health & Wellness +2%, Household -6%, Lifestyle -5%, International +7%.","CEO Linda Rendle reaffirms FY2026 outlook; cites recently announced GOJO acquisition."],"consensus_eps_estimate":null,"consensus_eps_actual":1.93,"consensus_revenue_estimate":null,"consensus_revenue_actual":3102000000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":112867,"accession_number":"0001206774-26-000048","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2026-01-22T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Clorox to acquire GOJO Industries (Purell) for $2.25B cash; net $1.92B after tax benefits","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $2.25B, including ~$330M tax benefits, net $1.92B; expected close before end of FY2026.","GOJO has ~$800M in annual sales with 5% 3-yr CAGR; Purell is #1 hand sanitizer in B2B and retail.","Transaction accretive to adjusted EPS in year two, neutral in year one; at least $50M in run-rate cost synergies.","Clorox reaffirms FY2026 net sales, diluted EPS and adjusted EPS outlook (excl. acquisition).","Funded primarily through debt financing; Centerview Partners acting as financial advisor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":1.0,"calibrated_materiality_score":1.0,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129292,"accession_number":"0001206774-25-000747","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2025-11-20T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Clorox shareholders elect all director nominees, approve say-on-pay and auditor ratification","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 11 director nominees elected with majority support; Linda Rendle received 81.2M for, 6.6M against (92.4% for).","Advisory vote on named executive officer compensation approved with 79.99M for (89.9% of votes cast).","Ratification of Ernst & Young as independent auditor for FY2026 approved with 99.33M for (94.7% of votes cast)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129291,"accession_number":"0000021076-25-000051","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2025-11-03T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q1 FY2026: Net sales down 19% to $1.43B, adj. EPS $0.85 (-54% YoY) on ERP disruption","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Diluted EPS $0.65 vs $0.80 prior year; adjusted EPS $0.85 vs $1.86 (-54%), largely due to ERP transition.","Gross margin fell 410 bps to 41.7% on lower volume and higher manufacturing/logistics costs.","Organic sales declined 17%, with volume down 15%; Health & Wellness segment sales -19%.","Operating cash flow $93M vs $221M (-58%); free cash flow $57M vs $182M.","Company cites expected ERP transition impact; no specific numerical guidance revision provided."],"consensus_eps_estimate":1.566,"consensus_eps_actual":0.65,"consensus_revenue_estimate":null,"consensus_revenue_actual":1429000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129290,"accession_number":"0001206774-25-000735","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Clorox EVP & COO Eric Reynolds resigns after 27 years; no replacement planned","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Eric Reynolds, EVP – Chief Operating and Strategy Officer, resigns after 27 years at Clorox.","Resignation effective December 2, 2025; advisory role through February 2, 2026.","Clorox will not appoint a replacement for Reynolds as COO and Strategy Officer.","Departure is a voluntary resignation; no named successor at this time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":145876,"accession_number":"0000021076-25-000035","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q4 adj EPS $2.87 (+58% YoY); organic sales +8% on ERP pull-forward; provides FY26 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $2.0B (+4% GAAP, +8% organic); incremental ERP shipments contributed ~13-14 points to sales.","Q4 adj EPS $2.87 vs $1.82 (+58%), including ~$0.85-0.95 benefit from ERP shipments.","FY25 free cash flow $761M (10.7% of sales) vs $483M (6.8%) prior year; capex $220M.","FY25 gross margin expanded 220 bps to 45.2% driven by cost savings of 190 bps.","Management notes topline below expectations in H2; FY26 outlook provided but no specific numbers in release."],"consensus_eps_estimate":1.4477,"consensus_eps_actual":6.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":7104000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164141,"accession_number":"0001206774-25-000377","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2025-05-23T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Clorox amends bylaws to add cure process for shareholder nomination deficiencies","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board adopted amended bylaws effective May 19, 2025.","New cure process allows shareholders to fix deficiencies in director nomination notices.","Company will notify shareholders of deficiencies and provide a specified cure period.","Amendment applies to nomination notices received within the bylaws' time window."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164140,"accession_number":"0001206774-25-000357","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Clorox Elects Gina Boswell, CEO of Bath & Body Works, to Board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Election effective May 19, 2025; Boswell will join Nominating, Governance & Corporate Responsibility Committee.","Boswell is CEO of Bath & Body Works, Inc. and also serves on its board.","Her prior senior roles include Unilever, Avon, Ford, and Estée Lauder.","Board size increases to 12 members with her appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164139,"accession_number":"0000021076-25-000021","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2025-05-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q3 sales fall 8% to $1.67B; adjusted EPS down 15% to $1.45; outlook cautious","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.67B, down 8% (organic -2%) on category slowdowns and unfavorable price mix.","Gross margin expanded 240 bps to 44.6% (10th consecutive quarter), driven by cost savings and divestitures.","GAAP diluted EPS $1.50 (up 466% from -$0.41) includes lapped Argentina loss and cyber insurance recoveries.","Adjusted EPS $1.45 (down 15% from $1.71) on lower sales, partially offset by higher gross margin.","CEO expects Q4 headwinds to persist; still forecasts organic sales growth and strong earnings growth for FY25."],"consensus_eps_estimate":0.7946,"consensus_eps_actual":3.84,"consensus_revenue_estimate":null,"consensus_revenue_actual":5116000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":181935,"accession_number":"0001206774-25-000171","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2025-03-28T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"Clorox enters $1.2B five-year unsecured revolving credit facility, replaces prior agreement","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $1.2B five-year unsecured revolving credit agreement signed March 25, 2025 with JPMorgan, Citi, and Wells Fargo as administrative agents.","Prior $1.2B credit agreement (due March 2027) terminated concurrently; no material termination fees incurred.","Facility available for general corporate purposes; only financial covenant is a consolidated interest coverage ratio.","Interest rate options: base rate or Term SOFR plus applicable margin based on credit rating.","Agreement includes customary representations, covenants, and events of default; committed lenders include major banks."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":181934,"accession_number":"0000021076-25-000010","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2025-02-03T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q2 net sales down 15%; Glad JV to wind down; adjusted EPS falls 28%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales fell 15% to $1.69B; organic sales down 9%; diluted EPS $1.54 (+105%) but adjusted EPS $1.55 (-28% YoY).","Gross margin improved 30 bps to 43.8% on cost savings, partially offset by lower cost absorption and higher manufacturing costs.","Clorox and P&G wind down Glad jt venture by Jan 31, 2026; Clorox to acquire P&G’s 20% interest.","YTD operating cash flow $401M (+132% YoY); free cash flow $309M (9.0% of sales)."],"consensus_eps_estimate":2.23,"consensus_eps_actual":2.34,"consensus_revenue_estimate":null,"consensus_revenue_actual":3448000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":181933,"accession_number":"0001206774-25-000035","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2025-01-28T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Clorox CFO Kevin Jacobsen to Retire April 1; Luc Bellet Named CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kevin Jacobsen, CFO since 2018, to retire effective April 1, 2025, after nearly 30 years at Clorox; will advise until June.","Luc Bellet, currently Treasurer and 18-year veteran, appointed EVP & CFO effective April 1; will report to CEO.","Bellet's base salary increased to $725,000; STI target doubled to 100% of salary; receives RSU ($400k, 4-yr vest) and PSU ($600k, 3-yr).","Transition is orderly with Jacobsen staying in advisory role through June 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":198590,"accession_number":"0001206774-24-001005","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2024-11-21T23:59:59+00:00","items":["5.07","8.01","9.01"],"status":"ready","headline":"Clorox adds two new directors to board; shareholders re-elect all nominees at 2024 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Shareholders elected all 11 director nominees, including new directors Stephen Bratspies and Pierre Breber, at Nov 20 annual meeting.","Bratspies, former Hanesbrands CEO, brings CPG and retail experience; Breber, former Chevron CFO, adds financial expertise.","Bratspies will serve on Audit committee; Breber on Audit and Nominating, Governance and Corporate Responsibility committees.","Board now has 11 members; previously disclosed that Amy Banse, Paul Parker, Kathryn Tesija did not stand for re-election.","Advisory vote on executive compensation passed with 83.2M votes for; Ernst & Young ratified as auditor for FY2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":198589,"accession_number":"0000021076-24-000038","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q1 FY2025: net sales +27% to $1.76B; adj. EPS $1.86 vs $0.49 YoY; raised outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Diluted EPS rose 371% to $0.80; adjusted EPS of $1.86 (+280% YoY) on strong ops and cyberattack lapping.","Organic sales up 31%; volume growth 26% driven by Health & Wellness (+38%), Household (+43%), Lifestyle (+48%).","Gross margin expanded 740 bps to 45.8% on higher volume and cost savings; FY2025 EPS and margin outlook raised.","Year-to-date operating cash flow $221M vs $20M a year ago; free cash flow $182M vs -$4M.","Better Health VMS divestiture completed Sep 10; one-time charge of $0.94/share in reported EPS."],"consensus_eps_estimate":null,"consensus_eps_actual":0.8,"consensus_revenue_estimate":null,"consensus_revenue_actual":1762000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214622,"accession_number":"0001206774-24-000894","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2024-09-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Clorox completes divestiture of Better Health VMS business to Piping Rock affiliate","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale includes Natural Vitality, NeoCell, Rainbow Light, RenewLife brands, related trademarks and licenses.","Manufacturing and distribution facilities in Sunrise, Florida transferred to buyer.","Clorox says the divestiture reduces volatility and improves margins to drive profitable growth.","No financial terms of the transaction were disclosed in the press release."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214621,"accession_number":"0000021076-24-000027","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q4 net sales -6% to $1.9B; adjusted EPS +9% to $1.82; divests VMS business","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP diluted EPS $1.73 (+22% YoY); adjusted EPS $1.82 (+9%) vs $1.67.","Gross margin 46.5% (+380 bps) on lower costs; organic sales -3%.","Announces sale of Better Health VMS business to Piping Rock Health Products; no deal value disclosed.","FY24 free cash flow $483M vs $930M; net cash from ops $695M.","FY25 outlook: expects return to volume growth consistent with long-term goals."],"consensus_eps_estimate":null,"consensus_eps_actual":2.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":7093000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233730,"accession_number":"0000021076-24-000014","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2024-04-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q3 net sales down 5% to $1.81B; adjusted EPS up 13% to $1.71","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales fell 5% to $1.81B; organic sales up 2% despite cyberattack disruptions.","Diluted EPS loss of $0.41 vs loss of $1.71 YoY; adjusted EPS rose 13% to $1.71.","Gross margin expanded 40 bps to 42.2% on pricing and cost savings.","YTD operating cash flow $355M, down 51%; free cash flow $224M vs $584M.","Divested Argentina business on Mar 20; expects full distribution recovery by Q4 end."],"consensus_eps_estimate":null,"consensus_eps_actual":0.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":5190000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251732,"accession_number":"0001206774-24-000281","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2024-03-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Clorox sells Argentina, Uruguay, Paraguay operations to Apex Capital; expects $233M charge","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sale to Apex Capital (Grupo Mariposa) and former Clorox exec Diego Barral; financial terms not disclosed.","Clorox Argentina represents ~2% of FY2024 net sales outlook.","One-time after-tax charge ~$233M in Q3 FY2024, mostly non-cash currency translation release.","Expected to reduce FY2024 net sales growth by ~0.5 points and adjusted EPS by $0.00-$0.02.","R&D and corporate hubs remain; production employees transfer to new entity 'Grupo Ayudin'."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251731,"accession_number":"0000021076-24-000008","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2024-02-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q2 net sales +16% to $1.99B; adj. EPS $2.16 vs $0.98 YoY; cyber recovery ahead of schedule","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.99B, up 16% YoY; organic sales +20% driven by volume rebuild from August cyberattack.","GAAP diluted EPS $0.75 (down 6%) includes $1.04 noncash pension settlement, $0.19 digital investment, $0.16 cyber costs.","Adjusted EPS $2.16, up 120% YoY; gross margin 43.5% (+730 bps) on pricing, cost savings, and volume absorption.","Health & Wellness segment net sales +25% (volume +22%); Household +9%; Lifestyle +21%; International +9%.","YTD operating cash flow $173M (-55%); free cash flow $97M vs $299M prior year."],"consensus_eps_estimate":null,"consensus_eps_actual":0.92,"consensus_revenue_estimate":null,"consensus_revenue_actual":3376000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":269269,"accession_number":"0001206774-23-001250","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2023-11-16T23:59:59+00:00","items":["5.07","8.01","9.01"],"status":"ready","headline":"Clorox CEO Linda Rendle to become Board Chair; Shattock to Lead Independent Director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Linda Rendle elected Board Chair effective Jan. 1, 2024; Matthew Shattock becomes Lead Independent Director.","Shattock, chair since 2021, retains duties including board agendas, independent director meetings, and CEO evaluations.","Rendle is a 20-year Clorox veteran who led Cleaning, International, Strategy & Operations prior to CEO role.","Board cites Rendle's leadership through pandemic, cyberattack, and digital transformation as confidence in her.","Rendle also serves on the boards of Visa Inc. and the Consumer Brands Association."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":269268,"accession_number":"0000021076-23-000046","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2023-11-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q1 net sales down 20% to $1.4B; diluted EPS 17¢ (-75%), adjusted EPS 49¢ (-47%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.4B, down 20%; organic sales down 18%; volume down 26%.","Diluted EPS 17¢ (down 75%); adjusted EPS 49¢ (down 47%); cyberattack caused 15¢ incremental expense.","Gross margin up 240 bps to 38.4% from 36.0% aided by pricing and cost savings.","Net cash from operations $20M, down 89% from $178M; capex $24M vs $46M.","Segments: Health & Wellness -23%, Household -23%, Lifestyle -28%, International -5% (organic +9%)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":1386000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":269267,"accession_number":"0001206774-23-001174","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2023-10-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Clorox warns Q1 net sales down ~25% on cyber attack; sees adjusted EPS loss up to $0.40","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Preliminary Q1 FY2024 net sales expected down 28% to 23% YoY; organic sales down 26%–21% vs prior mid-single-digit growth.","Gross margin expected down YoY; diluted EPS loss $0.75–$0.35; adjusted EPS loss $0.40–$0.00, driven by cyber attack.","August cybersecurity attack caused wide-scale order processing delays and product outages; automated ordering resumed Sept 25.","Ongoing but lessening operational impacts expected in Q2; full FY2024 outlook to be provided on November earnings call."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":286260,"accession_number":"0001206774-23-001133","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2023-09-18T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Clorox discloses cybersecurity incident causing material Q1 financial impact","summary_kind":"llm","event_type":"cyber","confidence":"high","bullets":["Identified unauthorized IT activity on Aug. 14, 2023; took systems offline to contain.","Attack damaged IT infrastructure, causing widescale operational disruption and manual order processing.","Production resumed at vast majority of sites; normal automated order processing to begin week of Sept. 25.","Q1 financial results expected to be materially impacted; longer-term outlook uncertain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":286259,"accession_number":"0001206774-23-000969","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2023-08-14T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Clorox reports cybersecurity incident causing disruption to IT systems and business operations","summary_kind":"llm","event_type":"cyber","confidence":"high","bullets":["Unauthorized activity identified on some IT systems; steps taken to stop and remediate, including taking systems offline.","Company is coordinating with law enforcement and has engaged leading third-party cybersecurity experts.","Incident has caused and is expected to continue causing disruption to parts of Clorox's business operations.","Workarounds implemented for certain offline operations to continue servicing customers where possible.","Investigation to assess nature and scope is ongoing and in early stages; no specific financial or data impact disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":286258,"accession_number":"0000021076-23-000030","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2023-08-02T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q4 net sales +12% to $2.0B, adjusted EPS $1.67, gross margin +560 bps","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales increased 12% to $2.0 billion; organic sales up 14%.","Gross margin expanded 560 bps to 42.7% driven by pricing and cost savings.","Diluted EPS $1.42 (up 75% YoY); adjusted EPS $1.67 (up 80% YoY).","Volume declined 2% overall; Health & Wellness organic sales +14%.","Free cash flow $930M for FY23 vs $535M prior year; capex $228M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":7389000000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":286257,"accession_number":"0001206774-23-000820","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2023-07-26T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Clorox Group President Rebecca Dunphey resigns effective Aug 11; Dan Dahlgren returns as interim","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Rebecca Dunphey, Group President of Care & Connection, resigns effective August 11, 2023.","Dan Dahlgren, a retired Clorox executive, will serve as interim leader of the Care & Connection group.","Company has initiated a search to permanently fill the vacancy left by Dunphey."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":306071,"accession_number":"0001206774-23-000721","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2023-05-26T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Clorox amends bylaws to add universal proxy rule requirements and emergency provisions","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Bylaws amended effective May 22, 2023, to add procedural requirements for shareholders using SEC's Universal Proxy Rule.","Shareholders must use a proxy card color other than white when soliciting proxies directly or indirectly.","New requirements for director nominations: additional disclosures, nominee interviews within 10 days, and compliance certification.","Added Article IX with emergency provisions for Board operating procedures during defined emergencies.","Amendments include clerical and conforming updates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":306070,"accession_number":"0000021076-23-000013","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2023-05-02T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q3 FY2023: adj EPS +15%, net sales +6%, raises full-year outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.91B (+6% YoY); organic sales +8%; gross margin 41.8% (+590 bps).","Adjusted EPS $1.51 (+15% YoY); GAAP diluted EPS loss $1.71 due to $445M impairment in vitamins.","YTD operating cash flow $728M, up 61% YoY; free cash flow $584M, 10.9% of sales.","Health & Wellness segment volume -16% but price/mix +23%; Lifestyle sales +15%.","Company raises FY2023 outlook citing pricing, cost savings, and strategic investments."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":5370000000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":325272,"accession_number":"0000021076-23-000005","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2023-02-02T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q2 EPS $0.80 ($0.98 adj.) beats; net sales +1% to $1.72B; gross margin up 320 bps","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.72B, +1% vs prior year; organic sales +4% driven by price mix (+14%) offsetting volume decline (-10%).","GAAP diluted EPS $0.80, +43%; adjusted EPS $0.98, +48%, reflecting pricing and cost savings despite higher costs.","Gross margin improved 320 bps to 36.2% from 33.0% due to price increases and cost savings, partly offset by commodities and manufacturing headwinds.","YTD net cash from operations $387M, up 74% from $222M; free cash flow $299M (8.7% of net sales).","CEO Linda Rendle said results were better than expected; company updated outlook amid ongoing margin recovery and strategic investments."],"consensus_eps_estimate":null,"consensus_eps_actual":1.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":3455000000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":343029,"accession_number":"0001206774-22-002671","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2022-11-17T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Clorox shareholders elect all 12 directors, approve say-on-pay, ratify auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 12 director nominees elected; lowest support was Matthew J. Shattock with 84.0M for, 2.3M against.","Advisory say-on-pay approved: 80.9M for, 5.2M against, 0.5M abstain.","Ernst & Young ratified as independent auditor for FY2023: 102.6M for, 1.9M against, 0.3M abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":343028,"accession_number":"0000021076-22-000033","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2022-11-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q1 sales down 4% to $1.74B; EPS falls 40%; confirms FY outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Diluted EPS of $0.68, down 40% YoY; adjusted EPS $0.93, down 23%.","Gross margin 36%, down 110 bps due to higher manufacturing, logistics, and commodity costs.","Organic sales fell 2%; volume down 15% overall, partially offset by 13% favorable price/mix.","Net cash from operations $178M, up 334% YoY; free cash flow $132M vs. -$11M a year ago.","CEO says results better than expected; maintains FY2023 outlook amid ongoing macro headwinds."],"consensus_eps_estimate":null,"consensus_eps_actual":0.68,"consensus_revenue_estimate":null,"consensus_revenue_actual":1740000000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":359589,"accession_number":"0000021076-22-000021","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2022-08-03T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q4 net sales flat, gross margin compressed; announces streamlined operating model; FY23 cautious","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales flat at $1.8B; organic sales +1%; diluted EPS $0.81 (+4% YoY); adjusted EPS $0.93 (-2%).","FY22 net sales $7.1B (-3% YoY); gross margin 35.8% vs 43.6% prior year; free cash flow $535M vs $945M.","Health & Wellness segment volume -18% in Q4; net sales -5% despite pricing benefits; three-year avg growth +3%.","Announces streamlined operating model to create faster, simpler company, move decision-making closer to consumers.","FY23 outlook: environment remains difficult with inflation and portfolio normalization; expects margin rebuilding."],"consensus_eps_estimate":null,"consensus_eps_actual":3.73,"consensus_revenue_estimate":null,"consensus_revenue_actual":7107000000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":378370,"accession_number":"0001206774-22-001423","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2022-05-18T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Clorox appoints Julia Denman and Stephanie Plaines to board of directors, expanding to 13 members","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Julia Denman, Microsoft Corp VP and head of internal audit, and Stephanie Plaines, former Sam's Club CFO for e-commerce, elected to Clorox board effective May 16, 2022.","Board expands from 11 to 13 members; now 46% female and 30% people of color.","Both expected to join audit committee at September 2022 board meeting.","Denman brings nearly 30 years experience at Microsoft and P&G; Plaines over 30 years at PepsiCo, Ahold, Walmart, Starbucks."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":378369,"accession_number":"0001193125-22-153023","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2022-05-17T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Clorox redeems $600M 3.05% Senior Notes (Sep 2022) and $500M 3.50% Senior Notes (Dec 2024)","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Redemption of $600M 3.05% Senior Notes due Sep 2022 on June 15, 2022 at par plus accrued interest.","Redemption of $500M 3.50% Senior Notes due Dec 2024 on June 12, 2022 at greater of par or make-whole price.","Total of $1.1B in senior notes being called early; no replacement debt announced in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":378368,"accession_number":"0001193125-22-147599","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2022-05-11T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Clorox completes $1.1B senior notes offering (4.400% due 2029 and 4.600% due 2032)","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$1.1B aggregate: $500M of 4.400% Senior Notes due 2029 and $600M of 4.600% Senior Notes due 2032.","Offering closed May 11, 2022; underwriting agreement executed May 5, 2022.","Use of proceeds was not specified in the filing.","Notes issued under indenture with U.S. Bank Trust Company as trustee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":378367,"accession_number":"0000021076-22-000015","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2022-05-02T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q3 FY2022: Net sales +2% to $1.8B; gross margin down 760 bps; adjusted EPS down 19%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales rose 2% to $1.8B; organic sales also up 2% vs flat prior year.","Gross margin fell 760 bps to 35.9% on higher manufacturing, logistics, and commodity costs.","Diluted EPS of $1.21 vs a loss of $0.49; adjusted EPS down 19% to $1.31.","YTD free cash flow $279M, down 58% from $661M in prior-year period.","Health & Wellness sales down 3%; Household +6%; Lifestyle +4%; International +1%."],"consensus_eps_estimate":null,"consensus_eps_actual":2.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":5306000000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":378366,"accession_number":"0001206774-22-001279","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2022-04-28T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Clorox signs second 12-year, 47 MW VPPA for renewable electricity from Enel Green Power","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["12-year agreement for 47 MW from Enel Green Power's Oklahoma wind farm starting Jan 2023.","Expected to cover about half of Clorox's U.S. and Canada renewable electricity needs.","Reduces nearly 160k metric tons of CO2 emissions annually, equivalent to 31,000 homes.","Replaces the need to purchase renewable energy credits (RECs) from the open market.","Supports Clorox's 2030 science-based targets and 2050 net zero commitment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":396634,"accession_number":"0001206774-22-000893","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2022-03-28T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"Clorox enters $1.2B five-year revolving credit facility, replaces existing facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Entered $1,200,000,000 five-year unsecured revolving credit agreement on March 25, 2022.","Terminated existing $1,200,000,000 credit agreement dated Nov 15, 2019; no material termination fees.","Joint lead arrangers: JPMorgan Chase, Citibank, Wells Fargo Securities; administrative agents as noted.","Proceeds for general corporate purposes; only financial covenant is consolidated interest coverage ratio."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":396633,"accession_number":"0001206774-22-000581","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2022-03-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Clorox Chief Growth Officer Tony Matta departs; Stacey Grier promoted to succeed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Tony Matta, EVP – Chief Growth Officer, leaves Clorox effective March 11, 2022.","Stacey Grier promoted from SVP – Chief Marketing and Strategy Officer to EVP – Chief Growth & Strategy Officer, effective March 14, 2022.","No reason for Matta's departure or specific compensation changes disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":396632,"accession_number":"0000021076-22-000005","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2022-02-03T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q2 net sales fall 8%, gross margin drops 1240 bps to 33%, EPS down 72%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.7B, down 8% vs prior year; organic sales -8% reflecting 10-point volume decline.","Gross margin 33% vs 45% a year ago, driven by higher manufacturing & logistics and commodity costs.","Diluted EPS $0.56 (down 72%); adjusted EPS $0.66 (down 67%) excluding strategic digital investments.","Health & Wellness segment net sales down 21%; Household +3%, Lifestyle +2%, International flat.","YTD free cash flow $113M vs $478M prior year; capex $109M; company cites ongoing cost pressures."],"consensus_eps_estimate":null,"consensus_eps_actual":1.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":3497000000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":415596,"accession_number":"0001206774-21-002755","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2021-11-17T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Clorox amends severance plans and shareholders approve stock plan at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved the amended 2005 Stock Incentive Plan with 80.1 million votes for, 3.8 million against.","All 11 director nominees were elected, including Linda Rendle, Matthew Shattock, and Amy Banse.","Ernst & Young LLP ratified as independent auditor for FY2022 with 101.3 million votes for.","Advisory vote on executive compensation passed with 78.0 million for, 5.9 million against.","Compensation Committee amended CIC and non-CIC severance plans, aligning definitions and adding one-year adverse amendment delay."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":415595,"accession_number":"0001206774-21-002680","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2021-11-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q1 FY2022 net sales fall 6%; EPS down 65% as gross margin drops 1090 bps","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales declined 6% to $1.8B; organic sales down 5% compared to 27% growth a year ago.","Gross margin fell 1090 basis points to 37.1% on higher commodity, manufacturing and logistics costs.","Diluted EPS fell 65% to $1.14; adjusted EPS declined 54% to $1.21.","Net cash from operations dropped 89% to $41M; free cash flow was negative $11M.","CEO Linda Rendle confirmed FY2022 outlook despite persistent cost pressures."],"consensus_eps_estimate":null,"consensus_eps_actual":1.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":1806000000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":433230,"accession_number":"0001206774-21-001938","cik":21076,"company_name":"CLOROX CO /DE/","ticker":"CLX","form_type":"8-K","filed_at":"2021-08-03T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clorox Q4 EPS sinks 68%, sales fall 9%; FY margins contract sharply","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Q4 diluted EPS $0.81, down 68% YoY; full-year diluted EPS down 24%.","Q4 net sales declined 9% with organic sales down 10%; Health & Wellness segment sales down 17%.","Gross margin in Q4 fell to 37.1% from 46.8% a year ago, driven by higher commodity and supply-chain costs.","Full-year free cash flow $945M vs $1,292M prior year; capital expenditures $331M.","Company delivered over $120M in cost savings; e-commerce nearly doubled in two years."],"consensus_eps_estimate":null,"consensus_eps_actual":5.58,"consensus_revenue_estimate":null,"consensus_revenue_actual":7341000000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":11716069537.146122,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}